Related Experiment Videos
Oral drug therapy for erectile dysfunction: overview and aeromedical implications
Alon Grossman1, Erez Barenboim, Bella Azaria
1Israel Air Force Aero Medical Center, Tel Hashomer, Israel. alon2209@net.co.il
Aviation, Space, and Environmental Medicine
|November 24, 2004
Summary
Erectile dysfunction affects millions globally and is a growing concern for civil aviators due to age and health conditions. This review examines oral treatments for erectile dysfunction and their implications for pilots.
Area of Science:
- Urology
- Aerospace Medicine
Background:
- Erectile dysfunction (ED) affects approximately 150 million men worldwide, with numbers projected to significantly increase.
- The prevalence of ED is notable in the aging civil aviation population, often linked to co-morbidities.
Purpose of the Study:
- To review oral treatment options for erectile dysfunction.
- To discuss the implications of these treatments for aviators.
Main Methods:
- Literature review of available oral erectile dysfunction therapies.
- Analysis of existing data on the safety and efficacy of these treatments in the context of aviation.
Main Results:
- Phosphodiesterase inhibitors have transformed ED management, increasing patient engagement with treatment.
- Specific considerations are necessary when prescribing ED medications to pilots due to occupational demands and health profiles.
Conclusions:
- Oral ED treatments offer viable options for aviators experiencing erectile dysfunction.
- Further research and specific guidelines are needed to ensure safe and effective use of ED treatments in the aviation community.